These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4769128)

  • 1. Placebo and neuroleptic drug response in schizophrenics in correlation with the "16PF" personality profiles.
    Boleloucký Z; Vinar O; Tosovský J
    Act Nerv Super (Praha); 1973 Aug; 15(3):164-5. PubMed ID: 4769128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial with Sulpiride and placebo in chronic schizophrenics (study of 89 patients using the Harris-Letemendía-Willems scale)].
    Mezquita Blanco J; Cubillo Sánchez J; Aizpiri Díaz J; Zubia Zubia B
    Arch Neurobiol (Madr); 1972; 35(5):453-72. PubMed ID: 4568565
    [No Abstract]   [Full Text] [Related]  

  • 3. The prediction of placebo effect in functional psychoses.
    Vinarová E; Vinar O
    Act Nerv Super (Praha); 1973 Mar; 15(1):53-4. PubMed ID: 4572683
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 5. Milipertine: an early evaluation in severely ill schizophrenics.
    Mielke DH; Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):324-6. PubMed ID: 4197256
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxypertine in the treatment of schizophrenia.
    Alapin B; Golebiewska M
    Act Nerv Super (Praha); 1967 Nov; 9(4):436-9. PubMed ID: 4889080
    [No Abstract]   [Full Text] [Related]  

  • 7. Thiothixene in schizophrenic psychoses.
    Vinar O; Taussigová D; Bastecký J
    Act Nerv Super (Praha); 1971; 13(3):174-7. PubMed ID: 4939830
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of therapeutic responsivity to thiothixene in schizophrenics.
    Sterlin C; Oliveros R; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):394-6. PubMed ID: 4882603
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinical trial of a structurally unique neuroleptic (SU-23397).
    Angrist BM; Sathananthan G; Thompson H; Gershon S
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):359-63. PubMed ID: 809249
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
    Overall JE; Hollister LE; Prusmack JJ; Shelton J; Pokorny A
    J Clin Pharmacol J New Drugs; 1969; 9(5):328-38. PubMed ID: 4899114
    [No Abstract]   [Full Text] [Related]  

  • 12. A double blind study of clomacran.
    Lampe WT
    Curr Ther Res Clin Exp; 1969 May; 11(5):300-6. PubMed ID: 4977403
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of neuroleptic effects from animal data.
    Vinar O; Krsiak M
    Adv Biochem Psychopharmacol; 1974; 9(0):675-83. PubMed ID: 4836228
    [No Abstract]   [Full Text] [Related]  

  • 14. A new peridol derivative in the treatment of chronic schizophrenia.
    Buchan T
    S Afr Med J; 1969 Mar; 43(10):283-5. PubMed ID: 5786640
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicl experience with flupenthixol in the treatment of chronic schizophrenia.
    Molcan J; Kukucová H; Koníková M
    Act Nerv Super (Praha); 1971; 13(3):180-1. PubMed ID: 5113828
    [No Abstract]   [Full Text] [Related]  

  • 17. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach.
    Baro F; Van Lommel R; Dom R; De Mesmaecker L
    Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between the hospital milieu and the response to phenothiazines in the treatment of schizophrenics.
    Klerman GL; Goldberg SG; Davis D
    Acta Psychiatr Belg; 1970 Nov; 70(6):716-29. PubMed ID: 4931261
    [No Abstract]   [Full Text] [Related]  

  • 19. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
    Angus JW; Go SH; Simpson GM
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
    [No Abstract]   [Full Text] [Related]  

  • 20. Clopenthixol in schizophrenia. Comparison of two groups of patients treated by the same drug.
    Vinar O; Bastecký J; Taussigová D; Formánková M; Růzicka S
    Act Nerv Super (Praha); 1967 Nov; 9(4):401-4. PubMed ID: 4889074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.